23.10
0.75 (3.36%)
| Previous Close | 22.35 |
| Open | 22.26 |
| Volume | 223,801 |
| Avg. Volume (3M) | 650,605 |
| Market Cap | 1,783,756,544 |
| Price / Earnings (Forward) | 9.34 |
| Price / Sales | 1.11 |
| Price / Book | 1.16 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -0.43% |
| Operating Margin (TTM) | 14.53% |
| Diluted EPS (TTM) | -0.090 |
| Quarterly Revenue Growth (YOY) | 11.50% |
| Quarterly Earnings Growth (YOY) | -2.00% |
| Total Debt/Equity (MRQ) | 128.55% |
| Current Ratio (MRQ) | 1.17 |
| Operating Cash Flow (TTM) | 129.38 M |
| Levered Free Cash Flow (TTM) | 90.15 M |
| Return on Assets (TTM) | 2.91% |
| Return on Equity (TTM) | -0.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Integra LifeSciences Holdings C | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.75 |
|
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 14.29% |
| % Held by Institutions | 91.18% |
| 52 Weeks Range | ||
| Median | 35.00 (51.52%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citizens Capital Markets | 26 Feb 2025 | 35.00 (51.52%) | Buy | 23.60 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Mar 2025 | Announcement | Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference |
| 25 Feb 2025 | Announcement | Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance |
| 04 Feb 2025 | Announcement | Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 |
| 14 Jan 2025 | Announcement | Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |